Sobi Informs Investors About Upcoming Q2 Report and Call

Upcoming Q2 Report Announcement from Sobi
Sobi is gearing up to share its financial insights for the second quarter of 2025 on July 16, 2025, at 08:00 CEST.
Conference Call Details
On the same day, Sobi invites all interested parties including investors, analysts, and media representatives to join a conference call at 14:00 CEST. This important call will feature a detailed presentation of the quarterly results followed by a Q&A session, encouraging attendees to engage with the company’s leadership actively.
How to Access the Presentation
Participants can tune into the live presentation directly or catch it later on Sobi’s official site. Additionally, presentation slides will be accessible ahead of the call on Sobi’s website to allow for thorough preparation.
Dial-in Information
For those wishing to participate in the conference call, please use the following numbers:
Sweden: +46 8 5051 0031
United Kingdom: +44 207 107 0613
United States: +1 631 570 5613
If you're joining from other countries, Sobi has provided additional dial-in options listed for your convenience on their website.
About Sobi
Sobi® is a dynamic global biopharmaceutical company dedicated to unlocking breakthrough innovations that improve the lives of individuals affected by rare diseases. With a team of approximately 1,900 professionals operating across diverse regions, including Europe, North America, the Middle East, Asia, and Australia, Sobi stands at the forefront of healthcare innovation. In the previous fiscal year, the company reported a significant revenue of about SEK 26 billion. Sobi’s stock (STO: SOBI) is publicly traded on Nasdaq Stockholm. More details about Sobi can be found on their official website.
Contact Information
For further inquiries, the Sobi Investor Relations team is readily accessible. You can find the contact details on their website. For media contacts, Sobi also provides a dedicated section to address media-related queries.
Gerard Tobin
Head of Investor Relations
Frequently Asked Questions
When is Sobi's Q2 report being published?
Sobi's Q2 report is set to be published on July 16, 2025.
What time is the conference call scheduled for?
The conference call is scheduled for 14:00 CEST on the same day as the report's publication.
How can I participate in the conference call?
You can participate by dialing in using the provided phone numbers for your region.
Will the presentation be available to view later?
Yes, the presentation will be available for later viewing on Sobi's official website.
What is Sobi's focus as a company?
Sobi is focused on developing innovative treatments for individuals living with rare diseases globally.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.